Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Historical Holders from Q3 2023 to Q1 2025

Symbol
SYRE on Nasdaq
CUSIP
00773J202
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
58.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
59.9M
Holdings value
$1.39B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
129
Number of buys
86
Number of sells
-41
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 6.2% $67.2M 3.62M RTW Investments, LP Dec 31, 2024
Venrock Healthcare Capital Partners III, L.P. 4.6% $49.8M 2.69M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
PERCEPTIVE ADVISORS LLC 4.4% -56% $47.8M -$186M 2.57M -79.6% Perceptive Advisors LLC Dec 31, 2024

Institutional Holders of Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 86.2K $1.39M +$90.5K $16.14 7
2024 Q4 59.9M $1.39B +$172M $23.28 129
2024 Q3 51.4M $1.51B +$36.7M $29.41 118
2024 Q2 50.4M $1.18B +$422M $23.51 106
2024 Q1 31.6M $1.2B +$171M $37.93 101
2023 Q4 28M $601M +$524M $21.52 54
2023 Q3 3.26M $39.9M +$39.9M $12.25 27